USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
Hri Research, Inc.
Address:
2315 Fifth Street
Berkeley, CA 94710
Phone:
N/A
URL:
N/A
EIN:
N/A
DUNS:
N/A
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $249,180.00 5
SBIR Phase II $1,884,364.00 4

Award List:

PHOTO CROSS-LINKABLE DNA OLIGONUCLEOTIDE PROBE TO HTLV-III

Award Year / Program / Phase:
1987 / SBIR / Phase I
Award Amount:
$50,000.00
Agency:
HHS
Principal Investigator:
George D Cimino Phd
Abstract:
N/a

PHOTO CROSS-LINKABLE DNA OLIGONUCLEOTIDE PROBE TO HTLV-III

Award Year / Program / Phase:
1989 / SBIR / Phase II
Award Amount:
$498,802.00
Agency:
HHS
Principal Investigator:
George D Cimino Phd
Abstract:
A psoralen-monoadducted, cross-linkable dna oligonucleotide probe to a conserved portion of the htlv-iii genome will be prepared and used in an innovative hybridization assay. theassay is conducted at the melting temperature of the respective probe-target hybrid using high concentrations of probe.… More

METHODS FOR PCR SAMPLE PREPARATION\TARGET CAPTURE

Award Year / Program / Phase:
1991 / SBIR / Phase I
Award Amount:
$49,950.00
Agency:
HHS
Principal Investigator:
Cimino, George D , Principal Investigator
Abstract:
The objective of this project is to develop rapid, high yield methods for the isolation and enrichment of specific nucleic acids from whole blood lysates. these methods will provide nucleic acid free of blood components which are inhibitory to the polymerase chain reaction (pcr). whole blood will be… More

VALIDATION TEST FOR PATHOGEN INACTIVATION USING THE PCR

Award Year / Program / Phase:
1991 / SBIR / Phase I
Award Amount:
$49,917.00
Agency:
HHS
Principal Investigator:
Lin, Lily , Principal Investigator
Abstract:
N/a

DECONTAMINATION OF PLATELET CONCENTRATES

Award Year / Program / Phase:
1991 / SBIR / Phase I
Award Amount:
$49,588.00
Agency:
HHS
Principal Investigator:
Lin, Lily , Principal Investigator
Abstract:
N/a

METHODS FOR PCR SAMPLE PREPARATION\HEME NEUTRALIZATION

Award Year / Program / Phase:
1991 / SBIR / Phase I
Award Amount:
$49,725.00
Agency:
HHS
Principal Investigator:
Lin, Lily , Principal Investigator
Abstract:
N/a

VALIDATION TEST FOR PATHOGEN INACTIVATION USING THE PCR

Award Year / Program / Phase:
1992 / SBIR / Phase II
Award Amount:
$461,351.00
Agency:
HHS
Principal Investigator:
Lin, Lily , Principal Investigator
Abstract:
Transfusion-associated transmissible diseases such as hepatitis and aids remain a significant problem despite extensive donor screening and improved testing of blood units. the demand for blood products for support of immunosuppressed patients undergoing chemotherapy and organ transplantation… More

DECONTAMINATION OF PLATELET CONCENTRATES

Award Year / Program / Phase:
1993 / SBIR / Phase II
Award Amount:
$463,184.00
Agency:
HHS
Principal Investigator:
Lin, Lily , Principal Investigator
Abstract:
In this phase i grant, we seek to develop a method to inactivate pathogenic human viruses in platelet concentrates expanding on their preliminary work using photochemical decontamination (pcd) with psoralen and uv-a light. preliminary data have been published showing that the combination of 8-mop… More

METHODS FOR PCR SAMPLE PREPARATION\HEME NEUTRALIZATION

Award Year / Program / Phase:
1993 / SBIR / Phase II
Award Amount:
$461,027.00
Agency:
HHS
Principal Investigator:
Lin, Lily , Principal Investigator
Abstract:
We assert that the principal inhibitor of taq polymerase in blood samples is heme. the goal is to develop chemical, photochemical, enzymatic, or affinity binding methods for the inactivation of heme with a long term objective of allowing polymerase chain reaction (pcr) to become a routine clinical… More